An investigation of oxidative stress and coenzyme Q10 levels in patients with head and neck squamous cell carcinomas
- 14 Downloads
The purpose of this study was to determine the oxidative states of head and neck squamous cell carcinoma (HNSCC) patients by measuring their plasma levels of malondialdehyde (MDA), an indicator of lipid peroxidation, 3-nitrotyrosine (3-NT), an indicator of protein oxidation, and the coenzyme Q10 (CoQ10), an important antioxidant, and compare them with healthy individuals.
Materials and methods
The plasma MDA, 3-NT and CoQ10 levels of 35 patients and 20 healthy individuals were measured with the high-performance liquid chromatography (HPLC) method. By comparing the patients’ smoking habits, stage of the disease, size of the primary tumor and the presence of lymph nodes and the values of healthy individuals, the oxidative stress load of HNSCC patients was determined.
The mean plasma MDA levels of carcinoma patients were two times higher than those of healthy individuals (p < 0.001). When the mean plasma 3-NT levels of patients and healthy individuals were compared, no significant difference was found (p > 0.05). The mean plasma CoQ10 level of patients was low when compared with healthy individuals; however, no significant difference was detected (p > 0.05). In addition, as the stage and tumor size increased in HNSCC patients, their non-enzymatic antioxidant levels significantly decreased (p < 0.05).
In HNSCC patients, lipo-oxidative damage increased while nitrosative stress did not change; however, antioxidant activity decreased which in turn increased both lipid peroxidation and oxidative stress. These findings support the contention that oxidative stress strongly reflects the health status of HNSCC patients.
KeywordsSquamous cell carcinoma Coenzyme Q10 Malondialdehyde 3-Nitrotyrosine Oxidative stress
This study was submitted as an oral presentation at the 35th Turkish National Otolaryngology—Head and Neck Surgery Congress on Novemder 2–6, 2013, in Antalya, Turkey. The authors thank Gregory Thomas Sullivan of the University of Queensland in Brisbane, Australia, for editing the English in an earlier version of this manuscript.
This study was funded as a Ondokuz Mayıs University Scientific Research Projects (projectnumber - TIP1904.12.030).
Compliance with ethical standards
Conflict of interest
The authors declare that there is no conflict related to this research.
Ethics committee approval (2012/07) was received from Ondokuz Mayis University, Faculty of Medicine. All procedures performed in this study that involved human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 1.Brockstein B, Masters G (eds) (2003) Headand Neck Cancer. Kluwer Academic Publishers, Dordrecht pp 1–295. ISBN 1-4020-7336-4Google Scholar
- 2.Siddartha SB, Kumari S, Rathan S, Babu S, Shetty S (2011) Status of serum sialic acid, antioxidant and lipid peroxidation in head and neck cancer patients. Res J Pharma Biol Chem Sci 2(1):1–5Google Scholar
- 12.Hoff HF, O’Neil J (1993) Structural and functional changes in LDL after modification with both 4-hydroxynonenal and malondialdehyde. J Lipid Res 34:1209–1217Google Scholar
- 15.Yaman H, Unlu A, Karabıcak U, Cimen B, Balabanlı B, Erbil MK, Torkozkan N (2000) Measurement of 3-Nitrotyrosine by high performance liquid chromatography. T Klin J Med Res 18:26–30Google Scholar
- 16.Gurkan AS, Dundar OB (2005) Coenzyme Q10. J Fac Pharm Ankara 34(2):129–154Google Scholar
- 17.Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC Cancer Staging Manual, 7th ed., Springer, New York, pp 21–100. ISBN 978-0-387-88440-0Google Scholar
- 25.Canbay E, Celik K, Kunt T, Ertemur M, Canbay E (2002) An alteration in glutathione peroxidase activity and lipid peroxidation levels in patients with laryngeal carcinoma. Cumhuriyet MedicalJournal 24(4):175–178Google Scholar
- 26.Kaur J, Politis C, Jacobs R (2016) Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action. Clin Oral Investig 20(2):315–319. https://doi.org/10.1007/s00784-015-1506-4. Epub 2015 Jun 17CrossRefGoogle Scholar
- 28.Malathi M, Vijay M, Shivashankara AR (2011) The role of oxidative stress and the effect of radiotherapy on the plasma oxidant-antioxidant status in head and neck cancer J Clin Diagn Res 5(2):225–249Google Scholar
- 29.Mrowicka M, Zielińska-Bliźniewska H, Pietkiewicz P, Olszewski J, Majsterek I (2015) Evaluation of selected indicators of antioxidant status in patients with head and neck cancer. Otolaryngol Pol 69(5):44–50Google Scholar
- 32.Dahiya K, Dhankhar R, Madaan H, Singh V, Arora K (2012) Nitric oxide and antioxidant status in head and neck carcinoma before and after radiotherapy. Ann Clin Lab Sci 42(1):94–97Google Scholar
- 38.Gaby AR (1996) The role of coenzyme Q10 in clinical medicine: part-I. Alt Med Rev 1(1):11–17Google Scholar